FDA Crackdown on Compounded GLP-1s (Regulatory): On February 6, 2026, the FDA announced a formal intent to restrict the use of active pharmaceutical ingredients (APIs) for non-approved compounded GLP-1 drugs, targeting "mass-marketed" alternatives from companies like Hims & Hers as the national supply of brand-name versions stabilized
Compare the numbers: What GLP-1 programs actually cost per month Cost alone shouldn't drive medication selectionclinical fit matters equally
Aftercare Once your infusion is complete, your nurse ensures youre comfortable before you leave and provides aftercare guidance tailored to your treatment
Whether you need help calculating your tirzepatide syringe dosage , understanding your reconstitution ratios , or planning your starting dose protocol , the resources are built for exactly this kind of decision-making
When the upper arm makes sense The upper arm offers a middle ground in absorption characteristics, falling between the abdomen and thigh in most pharmacokinetic comparisons
